BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bian S, Cai H, Cui Y, Liu W, Xiao C. Nanomedicine-Based Therapeutics to Combat Acute Lung Injury. Int J Nanomedicine 2021;16:2247-69. [PMID: 33776431 DOI: 10.2147/IJN.S300594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Albanawany NM, Samy DM, Zahran N, El-Moslemany RM, Elsawy SM, Abou Nazel MW. Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats. Drug Deliv 2022;29:2592-608. [PMID: 35945895 DOI: 10.1080/10717544.2022.2105445] [Reference Citation Analysis]
2 Zhang YB, Xu D, Bai L, Zhou YM, Zhang H, Cui YL. A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 2022;14:1974. [PMID: 36145722 DOI: 10.3390/pharmaceutics14091974] [Reference Citation Analysis]
3 Weng C, Li G, Zhang D, Duan Z, Chen K, Zhang J, Li T, Wang J. Nanoscale Porphyrin Metal-Organic Frameworks Deliver siRNA for Alleviating Early Pulmonary Fibrosis in Acute Lung Injury. Front Bioeng Biotechnol 2022;10:939312. [DOI: 10.3389/fbioe.2022.939312] [Reference Citation Analysis]
4 Huang C, You Q, Xu J, Wu D, Chen H, Guo Y, Xu J, Hu M, Qian H. An mTOR siRNA-Loaded Spermidine/DNA Tetrahedron Nanoplatform with a Synergistic Anti-Inflammatory Effect on Acute Lung Injury. Adv Healthc Mater 2022;11:e2200008. [PMID: 35167728 DOI: 10.1002/adhm.202200008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun L, Liu Y, Liu X, Wang R, Gong J, Saferali A, Gao W, Ma A, Ma H, Turvey SE, Fung SY, Yang H. Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury. Adv Sci (Weinh) 2022;9:e2104051. [PMID: 34816630 DOI: 10.1002/advs.202104051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Su R, Zhang Y, Zhang J, Wang H, Luo Y, Chan HF, Tao Y, Chen Z, Li M. Nanomedicine to advance the treatment of bacteria-induced acute lung injury. J Mater Chem B 2021;9:9100-15. [PMID: 34672317 DOI: 10.1039/d1tb01770e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Guohua F, Tieyuan Z, Rui W, Juan X. Oxypaeoniflorin Prevents Acute Lung Injury Induced by Lipopolysaccharide through the PTEN/AKT Pathway in a Sirt1-Dependent Manner. Oxid Med Cell Longev 2021;2021:6878026. [PMID: 34394832 DOI: 10.1155/2021/6878026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]